1 Min Read
Nov 30 (Reuters) - Delivra Corp
* Delivra reports record Q3 revenues and licensing agreement for the transdermal delivery of medical cannabis during the quarter
* Q3 loss per share c$0.06 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.